Hunan Er Kang Pharmaceutical (300267) — Free Cash Flow Generation Index
Hunan Er Kang Pharmaceutical (300267) has a Free Cash Flow Generation Index of 0.74x as of June 2023. Free cash flow of CN¥128.88 Million represents 1% of operating cash flow (CN¥174.55 Million). See 300267 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hunan Er Kang Pharmaceutical Free Cash Flow Generation Index (2008–2024)
Historical FCF Generation Index trend for Hunan Er Kang Pharmaceutical across 17 annual periods. Explore Hunan Er Kang Pharmaceutical debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year Free Cash Flow Generation Index for Hunan Er Kang Pharmaceutical. For the full company profile including market capitalisation, see 300267 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.17x | CN¥-28.91 Million | CN¥166.69 Million | CN¥195.60 Million | ▲ +71.3% |
| 2023 | -0.60x | CN¥-89.77 Million | CN¥148.42 Million | CN¥238.19 Million | ▼ -258.1% |
| 2022 | 0.38x | CN¥107.53 Million | CN¥281.02 Million | CN¥173.49 Million | ▲ +113.8% |
| 2021 | -2.77x | CN¥-256.65 Million | CN¥92.68 Million | CN¥349.33 Million | ▼ -15.7% |
| 2020 | -2.39x | CN¥-427.36 Million | CN¥178.53 Million | CN¥605.89 Million | ▼ -1407.8% |
| 2019 | 0.18x | CN¥81.60 Million | CN¥445.82 Million | CN¥364.21 Million | ▼ -16.5% |
| 2018 | 0.22x | CN¥27.17 Million | CN¥123.89 Million | CN¥96.72 Million | ▼ -64.7% |
| 2017 | 0.62x | CN¥428.30 Million | CN¥689.11 Million | CN¥258.92 Million | ▼ -81.5% |
| 2016 | 3.36x | CN¥1.63 Billion | CN¥486.50 Million | CN¥1.15 Billion | ▲ +59.8% |
| 2015 | 2.10x | CN¥1.09 Billion | CN¥518.96 Million | CN¥570.53 Million | ▼ -47.6% |
| 2014 | 4.01x | CN¥702.81 Million | CN¥175.38 Million | CN¥527.42 Million | ▲ +84.6% |
| 2013 | 2.17x | CN¥378.20 Million | CN¥174.22 Million | CN¥203.98 Million | ▼ -42.2% |
| 2012 | 3.75x | CN¥315.31 Million | CN¥84.02 Million | CN¥231.28 Million | ▲ +137.6% |
| 2011 | 1.58x | CN¥119.59 Million | CN¥75.72 Million | CN¥43.87 Million | ▼ -37.6% |
| 2010 | 2.53x | CN¥107.52 Million | CN¥42.47 Million | CN¥65.05 Million | ▼ -13.6% |
| 2009 | 2.93x | CN¥29.82 Million | CN¥10.18 Million | CN¥19.64 Million | ▼ -95.2% |
| 2008 | 60.81x | CN¥12.83 Million | CN¥211.00K | CN¥12.62 Million | — |